[Gastroesophageal reflux].
Katzka
David A
DA
Hospital of the University of Pennsylvania, Philadelphia, USA.
D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D018662:Fundoplication; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000628:therapy*; D006635:Histamine H2 Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010535:Laparoscopy; D054328:Proton Pump Inhibitors
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors
Gastroösophageale Refluxkrankheit.